ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
2,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,3,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5,6,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
8,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
9,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
12,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
13,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
14,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,3,Headache,Headaches NEC,Headaches,Nerv,N
15,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,5,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
16,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
16,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
16,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
18,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
18,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
18,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
19,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
19,3,Headache,Headaches NEC,Headaches,Nerv,N
19,4,Tic,Tic disorders,Changes in physical activity,Psych,N
20,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
20,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
21,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
22,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
22,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
23,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
24,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,3,Headache,Headaches NEC,Headaches,Nerv,N
24,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
25,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
26,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,2,Tic,Tic disorders,Changes in physical activity,Psych,N
27,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
27,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
27,3,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
28,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
28,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
28,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
29,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
29,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
29,4,Headache,Headaches NEC,Headaches,Nerv,N
29,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
29,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
29,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
30,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
30,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
30,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,6,Headache,Headaches NEC,Headaches,Nerv,N
30,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
30,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
31,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
34,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
35,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
36,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
37,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
37,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
38,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
39,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
39,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
39,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
39,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
40,1,Tic,Tic disorders,Changes in physical activity,Psych,N
41,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
42,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
43,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
44,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
44,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,1,Withdrawal hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
46,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
47,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
48,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
49,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
51,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
52,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
53,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
53,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
54,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
54,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
55,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
55,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
55,3,Change in sustained attention,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
55,4,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
55,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
55,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
56,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
56,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
56,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
56,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
57,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
58,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
58,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
60,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
60,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
60,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
61,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
62,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
62,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
63,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
63,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
64,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
64,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
66,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
66,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
67,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
67,3,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
67,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
67,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
67,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
67,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
68,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
69,1,Obsessive-compulsive symptom,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
70,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
70,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
71,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
72,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
72,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
72,4,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
72,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
73,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
73,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
73,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
73,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
73,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,6,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
73,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
73,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
73,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
73,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
73,11,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
73,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
73,13,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
73,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,15,Terminal insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
74,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
75,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
76,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
77,2,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
77,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
78,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
78,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
79,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
79,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
80,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
81,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
81,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
81,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
82,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
82,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
82,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
82,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
82,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
83,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
84,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
84,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
84,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
84,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
84,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
84,7,Headache,Headaches NEC,Headaches,Nerv,N
84,8,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
84,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
84,10,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
84,11,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
84,12,Physical product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,13,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,14,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,15,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,16,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,17,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
84,18,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
84,19,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
84,20,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,21,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,22,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
85,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
86,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
86,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
87,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
88,1,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
89,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
90,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
90,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
91,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
94,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
95,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
96,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
97,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
99,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
99,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
100,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
100,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
101,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
103,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
103,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
103,3,Headache,Headaches NEC,Headaches,Nerv,N
104,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
105,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
105,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
106,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
106,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
106,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
107,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
107,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
107,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,4,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
108,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
108,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
109,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
112,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
113,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
114,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
115,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
116,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
117,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
118,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
119,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
119,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
119,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
119,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
119,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
119,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
120,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
120,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
121,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
121,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
122,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
123,1,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
123,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
123,3,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
124,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
124,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
124,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
124,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
125,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
125,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
125,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
126,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
126,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
126,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,4,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
126,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
127,2,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
127,3,Tic,Tic disorders,Changes in physical activity,Psych,N
128,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
128,2,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
129,1,"Hallucination, tactile",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
130,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
131,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
131,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
132,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
133,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
133,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
134,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
135,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
136,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
137,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
137,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,3,Headache,Headaches NEC,Headaches,Nerv,N
138,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
138,2,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
139,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
140,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
141,1,Borderline personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
141,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
141,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
142,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
142,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
143,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
143,4,Fear of death,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
143,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
143,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
143,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,10,Physical assault,Criminal activity,Legal issues,SocCi,N
143,11,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
143,12,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
143,13,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
143,14,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
143,15,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
143,16,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
143,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
144,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
144,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
145,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
145,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
146,1,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
147,1,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
148,1,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
149,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
149,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
149,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
149,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
150,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
150,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
151,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
151,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
151,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
153,1,Ophthalmological examination,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
154,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
154,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
154,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
154,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
155,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
156,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
157,1,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
158,1,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
159,1,Acne,Acnes,Skin appendage conditions,Skin,N
159,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
159,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
159,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
161,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
161,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
162,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
163,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
163,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
164,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
165,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
166,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
166,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
166,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
167,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
167,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
168,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
168,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
169,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
169,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
170,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
170,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
170,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
170,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
171,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
171,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
172,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
173,1,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
174,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
174,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
175,1,Angelman's syndrome,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
175,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
176,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
176,2,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
177,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
177,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
178,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
179,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
180,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
180,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
180,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
180,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
181,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
181,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
182,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
182,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
183,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
183,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
183,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
183,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
183,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
184,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
185,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
185,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
185,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
185,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
185,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
185,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
186,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
186,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
186,4,Patient uncooperative,Social issues NEC,Lifestyle issues,SocCi,N
186,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
186,6,Product substitution error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
186,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
186,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
187,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
188,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
188,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
189,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
189,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
189,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
190,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
190,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
191,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
191,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
191,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
192,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
192,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
192,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
193,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
193,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
194,1,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
194,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
194,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
195,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
195,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
196,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
196,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
197,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
197,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
197,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
197,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
197,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
197,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
197,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
198,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
198,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
199,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
199,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
201,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
201,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
202,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
202,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
202,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
203,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
203,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
204,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
204,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
206,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
206,2,Insurance issue,Economic circumstances,Economic and housing issues,SocCi,N
206,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
206,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
206,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
207,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
207,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
208,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
208,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
208,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
208,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
208,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
209,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
209,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
209,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
210,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
211,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
211,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
212,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
212,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
213,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
213,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
214,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
214,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
214,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
215,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
215,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
215,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
215,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
216,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
216,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
217,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
218,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
218,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
219,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
219,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
219,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
220,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
220,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
220,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
221,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
221,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
222,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
222,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
223,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
223,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
224,2,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
224,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
224,4,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
224,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
225,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
225,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
225,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
226,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
228,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
229,1,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
229,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
229,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
229,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
230,2,Headache,Headaches NEC,Headaches,Nerv,N
230,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
231,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
231,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
231,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
232,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
232,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
232,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
233,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
233,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
234,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
234,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
